Testimonial | Will Larkin
Will Larkin is the racing manager for Malua Racing who have been using Arthramid vet for the past several years. “It’s a great product, we use Arthramid because we’ve…
Testimonial | Dr Stuart Vallance
Dr Stuart Vallance is a specialist equine surgeon who trained in America at UC Davis and has been back in Melbourne working racetrack practice and doing racehorse surgeries since…
Testimonial | JD Hayes, Lindsay Park Racing
JD Hayes trains in partnership with brother Ben, at Lindsay Park Racing. They came across Arthramid Vet when it was recommended by head veterinarian, Dave Mckellar and Alex Tremlett for…
Testimonial | Ben Gleeson
Assistant Trainer for Danny O’Brien for 5 years, Ben Gleeson has plenty of experience in the racing industry and knows a thing or two about keeping horses happy, sound and…
Testimonial | Dr Emma Wood
Dr Emma Wood has been in the racing industry most of her life but was a late bloomer to the veterinary world. She has been an assistant trainer both…
Understanding Equine Arthritis: An Owner Guide to Treatment and Ethical Considerations
Navigating the Treatment Pyramid, Orthobiologics, and the Nutraceutical Conundrum Introduction Equine arthritis is a prevalent and concerning health issue that affects horses worldwide. It not only poses welfare challenges…
Arthramid Vet Expands its Presence in the Middle East
Dr Jason Lowe recently spent a few weeks in the Middle East, establishing relationships and sharing his knowledge with executives from some of the top Equine Care Centres and Veterinary…
New Joint Therapies in Animals
As veterinarians we understand the complexity of disease processes associated with joint pain remains a constant dilemma in clinical practice and as with any disease process, an accurate diagnosis is…
Product Testimonial – Consider Arthramid Vet as a better treatment option for older patients or those with underlying metabolic disease.
Non-Pharmacological treatment offers veterinarians a better option for older and metabolic patients suffering from osteoarthritis (OA). Arthramid Vet’s 2.5% iPAAG technology is injected directly into the joint space providing lubrication…
Arthramid Vet: The last chance treatment that pulled through
Archie, a 7-year-old warmblood gelding on the brink of retirement due to persistent joint pain and inflammation has been given a second chance thanks to the innovative technology of the…
Japan Racing Association confirm no ban on the use of 2.5% polyacrylamide (PAAG) product Arthramid® Vet in Japan
Japan Racing Association (JRA) Anti-Doping Statement Regarding 2.5% PAAG Arthramid® Vet. The Japan Central Racing Association Feed and Drug Inspection Supervisory Committee Secretariat Anti-Doping Division, Horse Affairs Department have…
New technologies to aid in the treatment of osteoarthritis in dogs
Osteoarthritis (OA) is one of the most common chronic musculoskeletal diseases in dog populations, causing lameness and a loss of quality of life. It is estimated that 20-37% of dogs>…
